Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119358) titled 'Optimization of Intraoperative Cell-level Fluorescence Scanning Strategy Based on Margin Risk Stratification in Breast-Conserving Surgery: A Prospective Study' on Feb. 26.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Quanzhou first Hospital,Fujian
Condition:
Breast Cancer
Intervention:
Gold Standard:Postoperative permanent paraffin pathology (H&E staining)
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-01
Target Sample Size: Target condition:50;Difficult condition:10
Countries of Recruitment:
China
To know more, visit ht...